Company / Financials
Forte Biosciences, Inc. Financials
FY2018-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$41.0K
FY2019 · -16.3% YoY
Net Income
-$38.9M
FY2019 · -16.3% YoY
Profit Margin
-94948.8%
FY2019 · net income / revenue
ROE
-67.0%
FY2019 · return on equity
Total Assets
$28.2M
FY2019
Total Debt
-
FY2019
Equity
$58.1M
FY2019
ROA
-138.2%
FY2019 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$41.0K-16.3% YoYNet Income HistoryProfit after all expenses and taxes-$38.9M-16.3% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$37.6M-18.7% YoYSG&A Expense HistorySelling, general, and administrative expenses$8.6M+89.3% YoYR&D Expense HistoryResearch and development spending$29.1M+7.0% YoYInterest Expense HistoryCost of borrowing and debt obligations$1.9M-5.8% YoYIncome Tax HistoryTotal income tax expense$1.0K0.0% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$2.66+82.5% YoYShares Outstanding HistoryWeighted average diluted shares outstanding23.0M+15.7% YoYTotal Assets HistoryTotal value of all assets owned$28.2M-72.7% YoY